Revenue

The PXM leader surpassed the coveted 'Rule of 40' financial benchmark in 2025, signaling strong growth and profitability as it preps for an AI-driven future.

Fractal's new healthcare AI has surpassed leading models from OpenAI and Google, signaling a major leap for India's sovereign AI ambitions and public health.

Reaching over 90% of German mobile users, a new partnership aims to restore trust in the phone by displaying verified business names on incoming calls.

After a volatile market debut, the supersonic flight company hits the NYSE, signaling a new era for high-speed testing and air-launch services.

SpeedBuilder Systems hires Marcel Bagley, a veteran from Guidewire and DXC, to accelerate growth for its BindExpress Suite in the competitive P&C market.

The mobile health firm now reaches 25 states with its tech-driven model, aiming to close care gaps and answer federal critics of in-home assessments.

Sebring Resorts is redefining luxury with a motorsports-themed community where collectors and racers can live alongside the iconic Florida raceway.

Benefits giant Alight faces a massive $3.1B annual loss from a goodwill writedown, suspending its dividend to focus on debt reduction and AI innovation.

BrainsWay's strategic investment in BrainStim aims to expand Deep TMS access in Canada, targeting veterans and first responders with advanced mental health care.

With two blockbuster cancer drugs driving record revenue, all eyes are on Syndax's upcoming earnings call for its 2026 outlook and growth strategy.

The safety science giant posted record 2025 earnings and a strong 2026 outlook, sharpening its focus on high-growth tech with a key divestiture.

Five Alberta First Nations launch a legal challenge against a federal-provincial deal, citing a lack of consent for the world's largest proposed CCS project.

New five-year data for SYFOVRE shows a significant delay in geographic atrophy progression, offering long-term hope but also sparking clinical debate.

Auto parts giant LKQ Corporation explores a potential sale after 2025 profits fall, despite strong cash flow and a new restructuring plan.

At a major scientific conference, Seer Inc.'s Proteograph platform is taking center stage, promising deeper insights into Alzheimer's and heart disease.

Supremex reports strong Q4 growth driven by its packaging division, erasing nearly all debt and positioning itself for an aggressive future beyond envelopes.

AmpliTech launches mid-band 5G radios, aiming to accelerate Open RAN adoption and capture a slice of the booming private network and smart city market.

A new global study shows India leading in green energy commitment, while others lag. But the real challenge isn't just policy—it's a critical shortage of skills.

With a major €12.5M EU funding package, Step Pharma is fast-tracking dencatistat, a novel therapy targeting a key vulnerability in ovarian and endometrial cancers.

With a pivotal data release on the horizon, Passage Bio heads to two major conferences. Can its dementia gene therapy program win over Wall Street?